Newborn Screening Follow-up; Approved Guideline – Second Edition, NSB02A2
standard by Clinical and Laboratory Standards Institute, 05/01/2013

Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns, 2nd Edition, NBS03Ed2E
standard by Clinical and Laboratory Standards Institute, 08/07/2019

Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline (formerly I/LA31-A), NBS03AE
standard by Clinical and Laboratory Standards Institute,

Newborn Screening by Tandem Mass Spectrometry, NBS04Ed2E
standard by Clinical and Laboratory Standards Institute, 05/01/2017

Newborn Screening for Cystic Fibrosis; Approved Guideline (Formerly I/LA35-A), NBS05AE
standard by Clinical and Laboratory Standards Institute,

Newborn Blood Spot Screening for Severe Combined Immunodeficiency by Measurement of T-cell Receptor Excision Circles; Approved Guideline, NBS06AE
standard by Clinical and Laboratory Standards Institute, 04/01/2013

Newborn Blood Spot Screening for Pompe Disease by Lysosomal Acid alpha-Glucosidase Activity Assays, 1st Edition, NBS07Ed1E
standard by Clinical and Laboratory Standards Institute, 03/01/2017

Point-of-Care Connectivity; Approved Standard, POCT01A2E
standard by Clinical and Laboratory Standards Institute, 07/28/2006

Implementation Guide of POCT1 for Healthcare Providers; Proposed Guideline, POCT1-P
standard by Clinical and Laboratory Standards Institute, 01/01/2007